Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr-Jun;26(2):242-253.
doi: 10.4103/jomfp.jomfp_373_21. Epub 2022 Jun 28.

Sarcoidosis - A review article

Affiliations
Review

Sarcoidosis - A review article

C Sreeja et al. J Oral Maxillofac Pathol. 2022 Apr-Jun.

Abstract

Sarcoidosis is a granulomatous disorder of multiple organs, with lungs and lymphatic systems being the most frequently affected sites of the body. It was first reported in 1877 and has continued to engross both clinicians and scientists since that time. Because sarcoidosis being a diagnosis of exclusion, it demands the physician to rule out all the possible diagnosis. Most of the patients remain asymptomatic and this makes the disease remain unnoticed for a prolonged period. Later after years, the disease could be diagnosed after witnessing the patient being symptomatic or suffering from organ failures. It could affect middle aged people of any sexes, often its clinical features correlate with tuberculosis. On immunological and histopathological examination, it reveals noncaseating granuloma in simple terms. Glucocorticoids remain the standard drug now and then. Further research has to be done to know the exact pathogenesis, early detection and betterment in treatment plan of sarcoidosis. The current review article gives a brief knowledge about etiopathogenesis, Clinical features, upgraded diagnostic methods such as biomarkers detection and the organized treatment plan to treat sarcoidosis.

Keywords: Asteroid bodies; Schaumann bodies; glucocorticoids; granulomatous; kveim-slitzbach skin patch test; sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Flow Chart 1
Flow Chart 1
Explaining the mechanism involved in the granuloma formation
Figure 1
Figure 1
Pathogenesis of sarcoidosis
Figure 2
Figure 2
Inclusion bodies seen in sarcoidosis

Similar articles

Cited by

References

    1. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003;289:3300–3. - PubMed
    1. Chen ES, Moller DR. Sarcoidosis – Scientific progress and clinical challenges. Nat Rev Rheumatol. 2011;7:457–67. - PubMed
    1. Hutchinson J. Anomalous disease of the skin of the fingers: Case of livid papillary psoriasis. Illus. Clin Surg. 1877;1:42–3.
    1. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55. - PubMed
    1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–65. - PubMed